REQUEST A DEMO
Total
USD $0.00
Search more companies

Ikar Vita Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Lessors of Real Estate | General Medical and Surgical Hospitals | Drinking Places (Alcoholic Beverages)
Full name: Ikar Vita Sp. z o.o. Profile Updated: February 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Ikar Vita Sp. z o.o. is based in Poland. The head office is in Wroclaw. It operates in the Ambulatory Health Care Services sector. Ikar Vita Sp. z o.o. was incorporated on March 10, 2020. The company’s latest financial report indicates a net sales revenue increase of 8.2% in 2025. During that time, Ikar Vita Sp. z o.o.’s total assets grew by 38.46%. The net profit margin of Ikar Vita Sp. z o.o. decreased by 8.48% in 2025.

Headquarters
Ul. Zielonogorska 3/5
Wroclaw; Dolnoslaskie; Postal Code: 53-617

Contact Details: Purchase the Ikar Vita Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Ikar Vita Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Ikar Vita Sp. z o.o. report to view the information.
Incorporation Date:
March 10, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
95%
Subsidiaries
Centrum Ikar Sp. z o.o.
100%
Taszka Ikarus Sp. z o.o. sp. j.
Company Performance
Financial values in the chart are available after Ikar Vita Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
8.2%
Total Operating Revenue
8.2%
Operating Profit
-14.21%
EBITDA
-11.01%
Net Profit/Loss for the Period
-14.57%
Total Assets
38.46%
Total Equity
45.88%
Operating Profit Margin
-9.18%
Net Profit Margin
-8.48%
Return on Equity (ROE)
-22.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?